• Welcome to CRUK Cambridge Centre
    - Pancreatic Cancer Programme
  • EUROPAC: Reach study aiming
    for familial pancreatic cancer
    and hereditary pancreatitis
  • PemOla, a Phase II study combining pembrolizumab
    and olaparib in metastatic pancreatic
    adenocarcinoma patient with high tumour mutation
    burden, is open to recruitment now
  • Upcoming World Pancreatic Cancer Day Webinar
    on Cancer-associated Cachexia, 21st November,
    is open for registration now

About CRUK Cambridge Centre - Pancreatic Cancer Programme

The Pancreatic Cancer Programme, formerly known as Cambridge Pancreatic Cancer Centre (CPCC), is now one of the ten foundamental programmes within Cancer Research UK (CRUK) Cambridge Centre. We believe that clusters of multi-disciplinary excellence is the key to overcome the challenges in treating pancreatic cancer. Focusing on world-class trials of therapies showing effectiveness in research models, we aim to help patients seeking cutting-edge treatment opportunities.

Research Projects

The centre is involved in research ranging from scientific research into the biology of pancreatic cancer, identification of biomarkers...

Learn More

Clinical Trials

A variety of trials are currently open for recruitment at Addenbrooke’s Hospital in Cambridge.

Learn More

Recent Events

The Cambridge HPB Surgery Symposium, 24th June 2022, Møller Institute, Cambridge.

Learn More